期刊文献+

补心气口服液对慢性稳定型心绞痛患者生活质量影响及疗效观察 被引量:3

Effects of Buxinqi on quality of life and treatment for coronary artery disease patients with stable angina pectoris
原文传递
导出
摘要 目的:观察中药补心气口服液治疗慢性稳定型心绞痛的疗效及其对患者生活质量的影响。方法:将63例经冠状动脉造影确诊为稳定型心绞痛的患者随机分为2组:补心气口服液组,给服补心气口服液10 ml,tid;硝酸酯类组,给服硝酸异山梨酯10 mg,tid或单硝酸异山梨酯20 mg,bid;治疗12周后,比较2组疗效,并采用西雅图心绞痛调查问卷(SAQ)生活质量测定量表,评价2组治疗后生活质量改善的情况。结果:2组心电图疗效比较,差异无统计学意义(P>0.05),在改善临床症状和生活质量方面,补心气口服液组明显优于硝酸酯类组(P<0.05)。结论:补心气口服液能有效改善心肌缺血和临床症状,并能提高患者的生活质量。 Objective:To observe the effects of Buxinqi on quality of life and treatment for coronary heart disease(CHD) patients with stable angina pectoris(SAP).Method:A total of 63 CHD subjects with SAP diagnosed by coronary artery angiography(CAG) were divided into two groups.Patients were given Buxinqi 10 ml tid in research group(n=32) and Isosorbide Dinitrate10 mg tid or Isosorbide Mononitrate 20 mg bid in control group(n=31) for 12 weeks,respectively.SAQ(Seatle Angina Questionaire) was adopted in studying quality of life before and after treatment in these patients.Result:There was no significant difference in the changes of electrocardiogram(ECG) between the two groups(P0.05).Improvement of angina and quality of life in research group were much better than those in control group(P0.05).Conclusion:Buxinqi can significantly improve angina and quality of life in CHD patients with SAP.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第2期116-118,共3页 Journal of Clinical Cardiology
关键词 心绞痛 稳定型 生活质量 补心气口服液 angina pectoris stable quality of life Buxinqi
  • 相关文献

参考文献8

二级参考文献56

  • 1Spertus JA, Winders JA, Dewhurst TA, et al. Monitoring the quality of life in patients with coronary artery disease[J]. Am J cardiac,1994, 74(12): 1240 - 1244.
  • 2Garratt A M, Hutchinson A, Russell I. The UK version of the seattle angina questionnaire ( SAQ - UK): reliability, validity and responsiveness[J ] .J Clin Epidemiol, 2001, 54(9) :907 - 915.
  • 3Ware J, Gandek B. Overview of SF - 36 health survey and the international quality of life assessment (IQOLA) project [J ]. J Clin Epidemiol, 1998, 51(11) :903 - 912.
  • 4Lawson WE, Hui JC, Lang G. Treatment benefit in the enhanced external counterpulsation consortium. Cardiology, 2000,94 ( 1 ) :31-35.
  • 5Ryden L, Standl E, Bartnic M, et al. Guideline on diabetes, prediabetes and cardiovascular disease:executive summary. The Task Force on Diabetes and Cardiovascular Disease of European Society of Cardiology (ESC) and of the Euopean Association for the Study of Diabetes(EASD). Eur Heart J,2007,28( 1 ) :88-136.
  • 6Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology.J Am Coll Cardiol,1999,34(3) :912-948.
  • 7Campeau L. Letter: Grading of angina pectoris. Circulation 1976 :54(3) :522-523.
  • 8O'Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol, 2000,36(1) :326-340.
  • 9Gibbons Pal, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-sunanary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol, 2003,41 ( 1 ) : 159-168.
  • 10Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation, 2004,110(10) :1245-1250.

共引文献2172

同被引文献34

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部